Metabolic effects and efficacy of a triphasic oral contraceptive (norgestimate/ethinyl estradiol).
Andolsek
K M
KM
Department of Community & Family Medicine, Duke University Medical Center, Durham, North Carolina.
Burkman
R T
RT
Kafrissen
M E
ME
Olson
W
W
Osterman
J
J
D000328:Adult; D001786:Blood Glucose / Q000032:analysis / Q000187:drug effects; D002784:Cholesterol / Q000097:blood; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects / Q000494:pharmacology*; D004997:Ethinyl Estradiol / Q000009:adverse effects / Q000494:pharmacology*; D005260:Female; D006801:Humans; D007328:Insulin / Q000097:blood; D008055:Lipids / Q000097:blood; D008137:Longitudinal Studies; D008597:Menstrual Cycle / Q000187:drug effects*; D009644:Norgestrel / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000494:pharmacology; D014280:Triglycerides / Q000097:blood
D001786:Blood Glucose; D003277:Contraceptives, Oral, Combined; D007328:Insulin; D008055:Lipids; D014280:Triglycerides; D009644:Norgestrel; D004997:Ethinyl Estradiol; D002784:Cholesterol; C017576:norgestimate